Annual Quaterly
Annual
Quaterly
Operating Results Financial condition Cash Flows Per share data Major Indicators Segments Data Drug Fostering Program formulations "Growing"formulations Other
Operating Results Financial condition Cash Flows Segments Data Drug Fostering Program formulations "Growing"formulations Other

Other

*Japanese GAAP
XLS downloads
(Unit:millions of yen)
FY2013 FY2014 FY2015 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023
Investments※ 8,991 8,428 9,638 6,455 11,912 9,085 6,304 11,161 12,095 14,679 21,908
Capital investments 8,991 8,428 9,638 6,455 11,912 9,085 6,304 11,161 11,456 11,172 18,352
R&D expenses 5,949 6,252 5,968 6,087 6,048 5,926 6,270 6,631 7,313 7,594 8,288
Depreciation 4,871 5,387 5,059 5,629 6,157 6,362 6,406 8,210 8,743 10,101 10,235
provided by StockWeather.com,Inc.